| Product NDC: | 0703-5051 |
| Proprietary Name: | Desmopressin acetate |
| Non Proprietary Name: | Desmopressin acetate |
| Active Ingredient(s): | 4 ug/mL & nbsp; Desmopressin acetate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0703-5051 |
| Labeler Name: | Teva Parenteral Medicines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074888 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19971101 |
| Package NDC: | 0703-5051-03 |
| Package Description: | 10 VIAL in 1 TRAY (0703-5051-03) > 1 mL in 1 VIAL (0703-5051-01) |
| NDC Code | 0703-5051-03 |
| Proprietary Name | Desmopressin acetate |
| Package Description | 10 VIAL in 1 TRAY (0703-5051-03) > 1 mL in 1 VIAL (0703-5051-01) |
| Product NDC | 0703-5051 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Desmopressin acetate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19971101 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc. |
| Substance Name | DESMOPRESSIN ACETATE |
| Strength Number | 4 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |